STEROID–INDUCED OSTEOPOROSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS

Adachi, 1996, Vitamin D and calcium in the prevention of corticosteroid-induced osteoporosis: A 3 year follow-up, J Rheumatol, 23, 995 Adachi, 1997, Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis, N Engl J Med, 337, 382, 10.1056/NEJM199708073370603 Adami, 1991, The prevention of corticosteroid-induced osteoporosis with nandrolone decanoate, J Bone Miner Res, 15, 73, 10.1016/0169-6009(91)90111-C Adams, 1981, Effects of hydrochlorothiazide and dietary sodium restriction on calcium metabolism in corticosteroid-treated patients, Metabolism, 30, 217, 10.1016/0026-0495(81)90144-X Adinoff, 1997, Steroid-induced fractures and bone loss in patients with asthma, N Engl J Med, 337, 382 Agnusdei, 1995, Prevention of early postmenopausal bone loss using low doses of conjugated estrogens and a new, non-hormonal, bone active drug, ipriflavone, Osteoporosis Int, 5, 462, 10.1007/BF01626609 Albanese CV, Cudd E, MacIntyre I: Effect of ipriflavone on the isolated osteoclast [abstract]. In Proceedings of the First International Symposium on Osteoporosis and Metabolic Bone Diseases, London, 1992, p 83 Allen, 1998, Treatment of glucocorticoid-induced growth suppression with growth hormone. National Cooperative Growth Study, J Clin Endocrinol Metab, 83, 2824, 10.1210/jc.83.8.2824 1996, American College of Rheumatology Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis, Arthritis Rheum, 39, 1291 Arden, 1994, The safety of hormone replacement therapy (HRT) in systemic lupus erythematosus (SLE), Lupus, 3, 11, 10.1177/096120339400300104 Avioli, 1998, The role of calcitonin in the prevention of osteoporosis, Endocrinol Metab Clin North Am, 27, 418, 10.1016/S0889-8529(05)70013-X Azria, 1995, 25 Years of salmon calcitonin: From synthesis to therapeutic use, Calcif Tissue Int, 57, 405, 10.1007/BF00301940 Benvenuti, 1991, Effects of ipriflavone and its metabolites on a clonal osteoblastic cell line, J Bone Miner Res, 6, 987, 10.1002/jbmr.5650060913 Brandi, 1992, Flavonoids: Biochemical effects and therapeutic applications, Bone Miner, 19, S3, 10.1016/0169-6009(92)90861-7 Buckley, 1996, Calcium and vitamin D3 supplementation prevents bone loss in the spine secondary to low-dose corticosteroids in patients with rheumatoid arthritis, Ann Intern Med, 125, 961, 10.7326/0003-4819-125-12-199612150-00004 Canalis, 1996, Mechanisms of glucocorticoid action in bone: Implications to glucocorticoid-induced osteoporosis, J Clin Endocrinol Metab, 81, 3441, 10.1210/jc.81.10.3441 Canalis, 1983, Effect of glucocorticoids on type I collagen synthesis, alkaline phosphatase activity and deoxyribonucleic acid content in cultured rat calvariae, Endocrinology, 112, 931, 10.1210/endo-112-3-931 Canalis, 1990, Differential effects of continuous and transient treatment with parathyroid hormone related peptide on bone collagen synthesis, Endocrinology, 126, 1806, 10.1210/endo-126-4-1806 Cauley, 1993, Effects of thiazide diuretic therapy on bone mass, fractures and falls. The Study of Osteoporotic Fractures Research Group, Ann Intern Med, 118, 666, 10.7326/0003-4819-118-9-199305010-00002 Chappard, 1991, Cortical osteoclasts are less sensitive to etidronate than trabecular osteoclasts, J Bone Miner Res, 6, 673, 10.1002/jbmr.5650060704 Bouillon, 1991, Consensus Development Conference: Prophylaxis and treatment of osteoporosis, Osteoporos Int, 1, 114, 10.1007/BF01880454 Crilly, 1978, Hormonal status in normal, osteoporotic and corticosteroid-treated postmenopausal women, J R Soc Med, 71, 733, 10.1177/014107687807101006 Danneskiold-Samsoe, 1986, The influence of prednisone on the muscle morphology and muscle enzymes in patients with rheumatoid arthritis, Clin Sci, 71, 693, 10.1042/cs0710693 Dawson-Hughes, 1990, A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women, N Engl J Med, 323, 878, 10.1056/NEJM199009273231305 De, 1995, Pamidronate and uveitis, Br J Rheumatol, 34, 479, 10.1093/rheumatology/34.5.479 deGroen, 1996, Esophagitis associated with the use of alendronate, N Engl J Med, 335, 1016, 10.1056/NEJM199610033351403 Dempster, 1989, Bone histomorphometry in glucocorticoid-induced osteoporosis, J Bone Miner Res, 4, 137, 10.1002/jbmr.5650040202 Dempster, 1993, Anabolic actions of parathyroid hormone on bone, Endocr Rev, 14, 690 Demuinck Keizer-Schrama, 1992, Dose-response study of biosynthetic human growth hormone (GH) in GH-deficient children, J Clin Endocrinol Metab, 74, 898, 10.1210/jc.74.4.898 Deodhar, 1995, Longitudinal study of hand bone densitometry in rheumatoid arthritis, Arthritis Rheum, 38, 1204, 10.1002/art.1780380905 des Grottes, 1997, Retrobulbar optic neuritis after pamidronate administration in a patient with a history of cutaneous porphyria, Clin Rheumatol, 16, 93, 10.1007/BF02238770 Diamond, 1995, Cyclical etidronate plus ergocalciferol prevents glucocorticoid-induced bone loss in postmenopausal women, Am J Med, 98, 459, 10.1016/S0002-9343(99)80345-3 Dykman, 1984, Effect of oral 1,25-dihydroxyvitamin D and calcium on glucocorticoid-induced osteopenia in patients with rheumatic diseases, Arthritis Rheum, 27, 1336, 10.1002/art.1780271203 Dykman, 1984, Evaluation of factors associated with glucocorticoid-induced osteopenia in patients with rheumatic diseases, Arthritis Rheum, 27, 1336, 10.1002/art.1780271203 Eriksen, 1995, Drug therapy: Formation-stimulating regimens, 403 Fratzl, 1994, Abnormal bone mineralization after fluoride treatment in osteoporosis: A small-angle X-ray-scattering study, J Bone Miner Res, 9, 1541, 10.1002/jbmr.5650091006 Gallacher, 1989, Side-effects of pamidronate, Lancet, 2, 42, 10.1016/S0140-6736(89)90277-8 Gertz, 1995, Studies of the oral bioavailability of alendronate, Clin Pharmacol Ther, 58, 288, 10.1016/0009-9236(95)90245-7 Gohel, 1997, Glucocorticoids cause apoptosis in osteoblasts in vivo and in vitro [abstract], Transactions of the Orthopedic Research Society, 22, 183 Gonnelli, 1996, Ultrasound parameters in osteoporotic patients treated with salmon calcitonin: A longitudinal study, Osteoporos Int, 6, 303, 10.1007/BF01623389 Gough, 1994, Generalised bone loss in patients with early rheumatoid arthritis, Lancet, 344, 23, 10.1016/S0140-6736(94)91049-9 Goulding, 1988, Effects of chronic prednisolone treatment on bone resorption and bone composition in intact and ovariectomized rats and in ovariectomized rats receiving beta-estradiol, Endocrinology, 122, 482, 10.1210/endo-122-2-482 Grauer, 1990, In vitro detection of neutralizing antibodies after treatment of Paget's disease of bone with nasal salmon calcitonin, J Bone Miner Res, 5, 387, 10.1002/jbmr.5650050412 Grecu, 1990, Effective therapy of glucocorticoid-induced osteoporosis with medroxyprogesterone acetate, Calcif Tissue Int, 46, 294, 10.1007/BF02563818 Guaydier-Souquieres, 1996, In corticosteroid-treated respiratory diseases, monofluorophosphate increases lumbar bone density: A double-masked randomized study, Osteoporos Int, 6, 171, 10.1007/BF01623943 Hahn, 1981, Effects of short term glucocorticoid administration on intestinal calcium absorption and circulating vitamin D metabolite concentrations in man, J Clin Endocrinol Metab, 52, 111, 10.1210/jcem-52-1-111 Hahn, 1979, Altered mineral metabolism in glucocorticoid-induced osteopenia: Effect of 25-hydroxyvitamin D administration, J Clin Invest, 64, 655, 10.1172/JCI109506 Hall, 1994, Effect of hormone replacement therapy on bone mass in rheumatoid arthritis patients with and without steroids, Arthritis Rheum, 37, 1499, 10.1002/art.1780371014 Hodsman, 1989, The response of vertebral bone mineral density during the treatment of osteoporosis with sodium fluoride, J Clin Endocrinol Metab, 69, 932, 10.1210/jcem-69-5-932 Hseuh, 1978, Glucocorticoid inhibition of FSH-induced estrogen production in cultured rat granulosa cells, Steroids, 32, 639, 10.1016/0039-128X(78)90074-0 Jee, 1970, Corticosteroid and bone, Am J Anat, 129, 477, 10.1002/aja.1001290409 Johansson, 1992, Insulin-like growth factor-1 stimulates bone turnover in osteoporosis, Lancet, 339, 1619, 10.1016/0140-6736(92)91889-G Karkkainen, 1997, Postprandial parathyroid hormone response to four calcium-rich foodstuffs, Am J Clin Nutr, 65, 1726, 10.1093/ajcn/65.6.1726 Kasting, 1992, Retention of etidronate in human, dog and rat, J Bone Miner Res, 7, 513, 10.1002/jbmr.5650070507 Kaufman, 1992, Bone mineral status in growth hormone-deficient males with isolated and multiple pituitary deficiencies of childhood onset, J Clin Endocrinol Metab, 74, 118, 10.1210/jc.74.1.118 Kleerekoper, 1991, Fluoride and osteoporosis, Annu Rev Nutr, 11, 309, 10.1146/annurev.nu.11.070191.001521 Laan, 1993, Differential effects of glucocorticoids on cortical appendicular and cortical vertebral bone mineral content, Calcif Tissue Int, 52, 5, 10.1007/BF00675619 Lane, 1998, The science and therapy of glucocorticoid-induced bone loss, Endocrinol Metab Clin North Am, 27, 465, 10.1016/S0889-8529(05)70017-7 Lane, 1998, Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis, J Clin Invest, 102, 1627, 10.1172/JCI3914 Lane, 1995, Rheumatoid arthritis and bone mineral density in elderly women, J Bone Miner Res, 10, 257, 10.1002/jbmr.5650100212 Lindsay, 1998, The role of estrogen in the prevention of osteoporosis, Endocrinol Metab Clin North Am, 27, 399, 10.1016/S0889-8529(05)70012-8 Lissoni, 1997, Acute effects of pamidronate administration on serum levels of interleukin-6 in advanced solid tumour patients with bone metastases and their possible implications in the immunotherapy of cancer with interleukin-2, Eur J Cancer, 33, 304, 10.1016/S0959-8049(96)00417-0 Lo Cascio, 1984, Bone loss after glucocorticoid therapy, Calcif Tissue Int, 36, 435, 10.1007/BF02405356 Lukert, 1990, Glucocorticoid-induced osteoporosis: Pathogenesis and management, Ann Intern Med, 112, 352, 10.7326/0003-4819-112-5-352 Lukert, 1994, Glucocorticoid-induced osteoporosis, Rheum Dis Clin North Am, 20, 629, 10.1016/S0889-857X(21)00353-7 Lukert, 1992, Estrogen and progesterone replacement therapy reduces glucocorticoid-induced bone loss, J Bone Miner Res, 7, 1063, 10.1002/jbmr.5650070909 Lukert, 1986, Serum osteocalcin is increased in patients with hyperthyroidism and decreased in patients receiving glucocorticoids, J Clin Endocrinol Metab, 62, 1056, 10.1210/jcem-62-5-1056 MacAdams, 1986, Reduction of serum testosterone levels during chronic glucocorticoid therapy, Ann Intern Med, 104, 648, 10.7326/0003-4819-104-5-648 Manalagas, 1995, Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis, N Engl J Med, 332, 305, 10.1056/NEJM199502023320506 Marie, 1992, Stimulation of bone formation in osteoporosis in patients treated with fluoride associated with increased DNA synthesis by osteoblastic cells in vitro, J Bone Miner Res, 7, 103, 10.1002/jbmr.5650070115 Meunier, 1984, Bone histomorphometry in corticosteroid-induced osteoporosis and Cushing's syndrome, Adv Exp Med Biol, 171, 191 Michel, 1991, Predictors of fractures in early rheumatoid arthritis, J Rheumatol, 18, 804 Miler, 1996, Clinical utility of bone mass measurement in adults: Consensus of an international panel. The Society of Clinical Densitometry, Semin Arthritis Rheum, 25, 361, 10.1016/S0049-0172(96)80001-1 Montemurro, 1991, Prevention of corticosteroid induced osteoporosis with salmon calcitonin in sarcoid patients, Calcif Tissue Int, 49, 71, 10.1007/BF02565124 Mulder, 1994, Intermittent cyclical etidronate in the prevention of corticosteroid-induced bone loss, Br J Rheumatol, 33, 348, 10.1093/rheumatology/33.4.348 Mundy, 1998, Bone agents, 8.40.1 Narusawa, 1995, The effects of recombinant human insulin-like growth factor (rhIGF)-1 and rhIGF-1/IGF binding protein-3 administration on rat osteopenia induced by ovariectomy with concomitant bilateral sciatic neurectomy, J Bone Miner Res, 10, 1853, 10.1002/jbmr.5650101204 Nevitt, 1994, Epidemiology of osteoporosis, Rheum Dis Clin North Am, 20, 535, 10.1016/S0889-857X(21)00348-3 Nordin, 1997, Calcium and osteoporosis, Nutrition, 13, 664, 10.1016/S0899-9007(97)83011-0 Overgaard, 1989, Effect of salcatonin given intranasally on early postmenopausal bone loss, BMJ, 299, 477, 10.1136/bmj.299.6697.477 Pacifici, 1996, Postmenopausal osteoporosis: How the hormonal changes of menopause cause bone loss, 727 Pajus, 1993, Erythroderma after clodronate treatment, BMJ, 307, 484, 10.1136/bmj.307.6902.484 Pak, 1995, Treatment of postmenopausal osteoporosis with slow-release fluoride, Ann Intern Med, 123, 401, 10.7326/0003-4819-123-6-199509150-00001 Passeri, 1992, Effect of ipriflavone on bone mass in elderly osteoporotic women, Bone Miner, 19, S57, 10.1016/0169-6009(92)90867-D Paz-Pacheco, 1995, Intact parathyroid hormone levels are not elevated in glucocorticoid-treated patients, J Bone Miner Res, 10, 1713, 10.1002/jbmr.5650101114 Podbesek, 1983, Effects of two treatment regimes with synthetic human parathyroid hormone fragment on bone formation and the tissue balance of trabecular bone in greyhounds, Endocrinology, 112, 1000, 10.1210/endo-112-3-1000 Reeve, 1996, PTH: A future role in the management of osteoporosis?, J Bone Miner Res, 11, 440, 10.1002/jbmr.5650110404 Reginster, 1993, Prevention of osteoporosis with nasal salmon calcitonin: Effect of anti-salmon calcitonin antibody formation, Osteoporos Int, 3, 261, 10.1007/BF01623830 Reid, 1998, The roles of calcium and vitamin D in the prevention of osteoporosis, Endocrinol Metab Clin North Am, 27, 389, 10.1016/S0889-8529(05)70011-6 Reid, 1990, Determinants of vertebral mineral density in patients receiving long-term glucocorticoid therapy, Arch Intern Med, 150, 2545, 10.1001/archinte.150.12.2545 Reid, 1992, Lateral spine densitometry is a more sensitive indicator of glucocorticoid-induced bone loss, J Bone Miner Res, 7, 1221, 10.1002/jbmr.5650071014 Reid, 1992, Bone mineral density of the proximal femur and lumbar spine in glucocorticoid-treated asthmatic patients, Osteoporos Int, 2, 103, 10.1007/BF01623844 Reid, 1985, Plasma testosterone concentrations in asthmatic men treated with glucocorticoids, BMJ, 291, 574, 10.1136/bmj.291.6495.574 Rico, 1992, Salmon calcitonin reduces vertebral fracture rate in postmenopausal crush fracture syndrome, Bone Miner, 16, 131, 10.1016/0169-6009(92)90883-F Riggs, 1982, Effect of fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis. Comparison with conventional therapy, N Engl J Med, 306, 446, 10.1056/NEJM198202253060802 Ringe, 1987, Salmon calcitonin in the therapy of corticoid-induced osteoporosis, Eur J Clin Pharmacol, 33, 35, 10.1007/BF00610377 Rodan, 1996, Bisphosphonates: Mechanisms of action, J Clin Invest, 97, 2692, 10.1172/JCI118722 Rolla, 1994, Bisphosphonate-induced bronchoconstriction in aspirin-sensitive asthma, Lancet, 343, 426, 10.1016/S0140-6736(94)91267-X Rudman, 1990, Effects of human growth hormone in men over 60 years old, N Engl J Med, 323, 1, 10.1056/NEJM199007053230101 Ruegsegger, 1983, Corticosteroid-induced bone loss: A longitudinal study of alternate day therapy in patients with bronchial asthma using quantitative computed tomography, Eur J Clin Pharmacol, 25, 615, 10.1007/BF00542348 Saag, 1998, Effects of alendronate for two years on BMD and fractures in patients receiving glucocorticoids [abstract], J Bone Miner Res, 23, S182 Saag, 1998, Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis, New Engl J Med, 339, 292, 10.1056/NEJM199807303390502 Sakakura, 1975, Inhibition of luteinizing hormone secretion induced by synthetic LRH by long-term treatment with glucocorticoids in human subjects, J Clin Endocrinol Metab, 40, 774, 10.1210/jcem-40-5-774 Sambrook, 1987, Determinants of axial bone loss in rheumatoid arthritis, Arthritis Rheum, 30, 721, 10.1002/art.1780300701 Sambrook, 1993, Prevention of corticosteroid osteoporosis: A comparison of calcium, calcitriol and calcitonin, N Engl J Med, 328, 1747, 10.1056/NEJM199306173282404 Schott, 1995, Ultrasound discriminates patients with hip fracture equally well as dual energy X-ray absorptiometry and independently of bone mineral density, J Bone Miner Res, 10, 243, 10.1002/jbmr.5650100210 Segal, 1996, Osteoporosis and systemic lupus erythematosus: Etiology and treatment strategies, Ann Med Intern, 147, 281 Seitz, 1985, Enhanced prostanoid release from monocytes of patients with rheumatoid arthritis and active systemic lupus erythematosus, Ann Rheum Dis, 44, 438, 10.1136/ard.44.7.438 Star, 1994, Osteoporosis in patients with rheumatic diseases, Rheum Dis Clin North Am, 20, 561, 10.1016/S0889-857X(21)00349-5 Storm, 1993, Changes in bone histomorphometry after long-term treatment with intermittent, cyclic etidronate for postmenopausal osteoporosis, J Bone Miner Res, 8, 199, 10.1002/jbmr.5650080211 Struys, 1995, Cyclical etidronate reverses bone loss of the spine and proximal femur in patients with established osteoporosis, Am J Med, 99, 235, 10.1016/S0002-9343(99)80154-5 Suzuki, 1983, Importance of increased urinary calcium excretion in the development of secondary hyperparathyroidism of patients under glucocorticoid therapy, Metabolism, 32, 151, 10.1016/0026-0495(83)90221-4 Tanaka, 1989, Spontaneous production of bone-resorbing lymphokines by B-cells in patients with systemic lupus erythematosus, J Clin Immunol, 9, 415, 10.1007/BF00917107 Thompson, 1997, Not all postmenopausal women on chronic steroids and estrogen treatment are osteoporotic. Predictors of bone mineral density, Calcif Tissue Int, 61, 377, 10.1007/s002239900351 van Vollenhoven, 1994, An open study of dehydroepiandrosterone in systemic lupus erythematosus, Arthritis Rheum, 37, 1305, 10.1002/art.1780370906 Verbruggen, 1981, Inhibition of collagen and sulfated glucosaminoglycan synthesis in neonatal mouse dermal fibroblasts by corticosterone, Biochem Pharmacol, 30, 3285, 10.1016/0006-2952(81)90600-6 Vitte, 1996, Bisphosphonates induce osteoblasts to secrete an inhibitor of osteoclast-mediated resorption, Endocrinology, 137, 2324, 10.1210/en.137.6.2324 Watts, 1998, Treatment of osteoporosis with bisphosphonates, Endocrinol Metab Clin North Am, 27, 419, 10.1016/S0889-8529(05)70014-1 Weinstein, 1998, Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone, J Clin Invest, 102, 274, 10.1172/JCI2799 Wolinsky-Friedland, 1995, Drug-induced metabolic bone disease, Endocrinol Metab Clin North Am, 24, 395, 10.1016/S0889-8529(18)30046-X